These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 15038508)

  • 1. Severity of ovarian hyperstimulation syndrome: its relation to number of conceptuses.
    Koike T; Minakami H; Araki S; Sayama M; Matsubara S; Suzuki M
    Int J Fertil Womens Med; 2004; 49(1):36-42. PubMed ID: 15038508
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Early and late ovarian hyperstimulation syndrome: early pregnancy outcome and profile.
    Papanikolaou EG; Tournaye H; Verpoest W; Camus M; Vernaeve V; Van Steirteghem A; Devroey P
    Hum Reprod; 2005 Mar; 20(3):636-41. PubMed ID: 15576388
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Conservative management of ovarian hyperstimulation syndrome.
    Morris RS; Miller C; Jacobs L; Miller K
    J Reprod Med; 1995 Oct; 40(10):711-4. PubMed ID: 8551473
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of the oral contraceptive pill on patients undergoing controlled ovarian hyperstimulation.
    Frederick J; DaCosta V; Wynter S; Reid M; Frederick C; McKenzie C
    West Indian Med J; 2004 Jan; 53(1):39-43. PubMed ID: 15114893
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Short coasting of 1 or 2 days by withholding both gonadotropins and gonadotropin-releasing hormone agonist prevents ovarian hyperstimulation syndrome without compromising the outcome.
    Moon HS; Joo BS; Moon SE; Lee SK; Kim KS; Koo JS
    Fertil Steril; 2008 Dec; 90(6):2172-8. PubMed ID: 18439601
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Follicular aspiration during the selection phase prevents severe ovarian hyperstimulation in patients with polycystic ovary syndrome who are undergoing in vitro fertilization.
    Zhu WJ; Li XM; Chen XM; Zhang L
    Eur J Obstet Gynecol Reprod Biol; 2005 Sep; 122(1):79-84. PubMed ID: 16154042
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Odds of ovarian hyperstimulation syndrome (OHSS) - time for reassessment.
    Mocanu E; Redmond ML; Hennelly B; Collins C; Harrison R
    Hum Fertil (Camb); 2007 Sep; 10(3):175-81. PubMed ID: 17786650
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Incidence and prediction of ovarian hyperstimulation syndrome in women undergoing gonadotropin-releasing hormone antagonist in vitro fertilization cycles.
    Papanikolaou EG; Pozzobon C; Kolibianakis EM; Camus M; Tournaye H; Fatemi HM; Van Steirteghem A; Devroey P
    Fertil Steril; 2006 Jan; 85(1):112-20. PubMed ID: 16412740
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Number of oocytes retrieved and resulting pregnancy. Risk factors for ovarian hyperstimulation syndrome.
    Reljic M; Vlaisavljević V; Gavrić V; Kovacic B
    J Reprod Med; 1999 Aug; 44(8):713-8. PubMed ID: 10483542
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The optimal length of 'coasting protocol' in women at risk of ovarian hyperstimulation syndrome undergoing in vitro fertilization.
    Nardo LG; Cheema P; Gelbaya TA; Horne G; Fitzgerald CT; Pease EH; Brison DR; Lieberman BA
    Hum Fertil (Camb); 2006 Sep; 9(3):175-80. PubMed ID: 17008270
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of the ovulatory serum concentration of human chorionic gonadotropin on the incidence of ovarian hyperstimulation syndrome and success rates for in vitro fertilization.
    Shapiro BS; Daneshmand ST; Garner FC; Aguirre M; Ross R; Morris S
    Fertil Steril; 2005 Jul; 84(1):93-8. PubMed ID: 16009163
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Management of severe ovarian hyperstimulation syndrome by ascitic fluid aspiration and intensive intravenous fluid therapy.
    Aboulghar MA; Mansour RT; Serour GI; Sattar MA; Amin YM; Elattar I
    Obstet Gynecol; 1993 Jan; 81(1):108-11. PubMed ID: 8416442
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A randomized controlled trial evaluating metformin pre-treatment and co-administration in non-obese insulin-resistant women with polycystic ovary syndrome treated with controlled ovarian stimulation plus timed intercourse or intrauterine insemination.
    Palomba S; Falbo A; Orio F; Manguso F; Russo T; Tolino A; Annamaria C; Dale B; Zullo F
    Hum Reprod; 2005 Oct; 20(10):2879-86. PubMed ID: 15958399
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Outcome of pregnancies complicated by severe ovarian hyperstimulation syndrome (OHSS): a follow-up beyond the second trimester.
    Wiser A; Levron J; Kreizer D; Achiron R; Shrim A; Schiff E; Dor J; Shulman A
    Hum Reprod; 2005 Apr; 20(4):910-4. PubMed ID: 15618246
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Migraines and ovarian hyperstimulation syndrome: a dopamine connection.
    Rollene NL; Khan Z; Schroeder DR; Cutrer FM; Coddington CC
    Fertil Steril; 2011 Jan; 95(1):417-9. PubMed ID: 20889153
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Abnormal human chorionic gonadotropin levels and normal pregnancy outcomes in the ovarian hyperstimulation syndrome.
    Samuel MJ; Grosskinsky CM
    J Reprod Med; 2004 Jan; 49(1):8-12. PubMed ID: 14976788
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Obstetric outcome of women with in vitro fertilization pregnancies hospitalized for ovarian hyperstimulation syndrome: a case-control study.
    Courbiere B; Oborski V; Braunstein D; Desparoir A; Noizet A; Gamerre M
    Fertil Steril; 2011 Apr; 95(5):1629-32. PubMed ID: 21215968
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Some aspects of ovarian hyperstimulation syndrome].
    Kovachev E; Kozovski I; Markova V; Andronov M; Cherneva S; Aleksandrov K
    Akush Ginekol (Sofiia); 2003; 42(6):37-41. PubMed ID: 15067814
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Short and long-term risks to women who conceive through in vitro fertilization.
    Gelbaya TA
    Hum Fertil (Camb); 2010 Mar; 13(1):19-27. PubMed ID: 19929571
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Plasma levels of soluble vascular endothelial growth factor receptor-1 may determine the onset of early and late ovarian hyperstimulation syndrome.
    Pau E; Alonso-Muriel I; Gómez R; Novella E; Ruiz A; García-Velasco JA; Simón C; Pellicer A
    Hum Reprod; 2006 Jun; 21(6):1453-60. PubMed ID: 16488907
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.